We are live on ! Find out more
MBOT icon

Microbot Medical

33 hedge funds and large institutions have $11.1M invested in Microbot Medical in 2015 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 9 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

90% more capital invested

Capital invested by funds: $5.83M → $11.1M (+$5.23M)

18% less funds holding

Funds holding: 4033 (-7)

22% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 9

78% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 9

Holders
33
Holders Change
-7
Holders Change %
-17.5%
% of All Funds
0.88%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
7
Reduced
9
Closed
9
Calls
Puts
Net Calls
Net Calls Change

MBOT Hedge Fund Activity: Q1 2015 in Review

33 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Microbot Medical (MBOT) for Q1 2015, worth a combined $11.1M — up 90% from $5.83M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of MBOT and 2 opened new positions — a net loss of 7 holders — while 9 trimmed existing stakes and 7 added.

The largest buyer was Vanguard Group, adding an estimated $213K. The largest seller was Sabby Management, cutting an estimated $1.25M.

  • 33 institutional investors held Microbot Medical (MBOT) as of Q1 2015, down from 40 in Q4 2014.
  • Funds reported $11.1M of Microbot Medical stock for Q1 2015, up 90% quarter-over-quarter.
  • 2 funds opened new Microbot Medical positions in Q1 2015 and 9 closed out, a net change of -7 holders.
  • The largest Microbot Medical buyer in Q1 2015 was Vanguard Group, an estimated $213K added.
  • The largest Microbot Medical seller in Q1 2015 was Sabby Management, an estimated $1.25M sold.

Based on aggregated 13F filings for Q1 2015.